Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.

about

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin.

Item

http://www.wikidata.org/entity/Q36906018

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Management of dyslipidemia and ...... f sitagliptin and simvastatin.

@en

type

Item

label

Management of dyslipidemia and ...... f sitagliptin and simvastatin.

@en

prefLabel

Management of dyslipidemia and ...... f sitagliptin and simvastatin.

@en

P1476

Management of dyslipidemia and ...... f sitagliptin and simvastatin.

@en

P2093

Helmut Steinberg

http://www.w3.org/2001/XMLSchema#string

Mary E Hanson

http://www.w3.org/2001/XMLSchema#string

Matt S Anderson

http://www.w3.org/2001/XMLSchema#string

Samuel S Engel

http://www.w3.org/2001/XMLSchema#string

Thomas Musliner

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

P304

273-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2147/VHRM.S44330

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23761972

http://www.w3.org/2001/XMLSchema#string

P921

lipid metabolism disorder

P932

3673969

http://www.w3.org/2001/XMLSchema#string